Kevin Lokay
Director/Board Member bei GALERA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Kevin G.
Lokay is an Independent Director at Galera Therapeutics, Inc. since 2019 and the Head-Change Implementation at AstraZeneca PLC since 2018.
Previously, he served as the President & Chief Executive Officer at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. from 2001 to 2008 and as the Vice President & Head-Business Unit at Boehringer Ingelheim Corp.
from 2009 to 2016.
He holds an undergraduate degree from Lafayette College and an MBA from Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Kevin Lokay
| Unternehmen | Position | Beginn |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Director/Board Member | 01.03.2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.08.2018 |
Ehemalige bekannte Positionen von Kevin Lokay
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01.12.2016 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Chief Executive Officer | 01.01.2008 |
Ausbildung von Kevin Lokay
| Lafayette College | Undergraduate Degree |
| Purdue University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
